- Home
- TNXP vs MFH Comparison
TNXP vs MFH Comparison
Compare TNXP & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- MFH
- Stock Information
- Founded
- TNXP 2007
- MFH 2011
- Country
- TNXP United States
- MFH United States
- Employees
- TNXP N/A
- MFH N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- MFH Finance: Consumer Services
- Sector
- TNXP Health Care
- MFH Finance
- Exchange
- TNXP Nasdaq
- MFH Nasdaq
- Market Cap
- TNXP 272.0M
- MFH 247.1M
- IPO Year
- TNXP N/A
- MFH N/A
- Fundamental
- Price
- TNXP $35.48
- MFH $4.09
- Analyst Decision
- TNXP Strong Buy
- MFH
- Analyst Count
- TNXP 2
- MFH 0
- Target Price
- TNXP $585.00
- MFH N/A
- AVG Volume (30 Days)
- TNXP 729.5K
- MFH 541.1K
- Earning Date
- TNXP 08-15-2025
- MFH 07-15-2025
- Dividend Yield
- TNXP N/A
- MFH N/A
- EPS Growth
- TNXP N/A
- MFH N/A
- EPS
- TNXP N/A
- MFH N/A
- Revenue
- TNXP $10,041,000.00
- MFH N/A
- Revenue This Year
- TNXP $11.66
- MFH N/A
- Revenue Next Year
- TNXP $793.18
- MFH N/A
- P/E Ratio
- TNXP N/A
- MFH N/A
- Revenue Growth
- TNXP N/A
- MFH 125.92
- 52 Week Low
- TNXP $6.76
- MFH $1.03
- 52 Week High
- TNXP $130.00
- MFH $8.86
- Technical
- Relative Strength Index (RSI)
- TNXP 52.96
- MFH 52.50
- Support Level
- TNXP $33.71
- MFH $3.80
- Resistance Level
- TNXP $38.13
- MFH $4.41
- Average True Range (ATR)
- TNXP 2.62
- MFH 0.39
- MACD
- TNXP -0.44
- MFH 0.12
- Stochastic Oscillator
- TNXP 61.01
- MFH 90.35
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.